[Congressional Bills 107th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5719 Introduced in House (IH)]







107th CONGRESS
  2d Session
                                H. R. 5719

 To amend part B of title XVIII of the Social Security Act to provide 
 coverage of certain self-administered intramuscular and subcutaneous 
                   drugs under the Medicare Program.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                           November 13, 2002

  Mr. Greenwood (for himself and Mr. Waxman) introduced the following 
 bill; which was referred to the Committee on the Energy and Commerce, 
and in addition to the Committee on Ways and Means, for a period to be 
subsequently determined by the Speaker, in each case for consideration 
  of such provisions as fall within the jurisdiction of the committee 
                               concerned

_______________________________________________________________________

                                 A BILL


 
 To amend part B of title XVIII of the Social Security Act to provide 
 coverage of certain self-administered intramuscular and subcutaneous 
                   drugs under the Medicare Program.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. COVERAGE OF CERTAIN SELF-ADMINISTERED INTRAMUSCULAR AND 
              SUBCUTANEOUS DRUGS UNDER THE MEDICARE PROGRAM.

    (a) In General.--Section 1861(s)(2) of the Social Security Act (42 
U.S.C. 1395x(s)(2)) is amended --
            (1) by striking ``and'' at the end of subparagraph (U);
            (2) by inserting ``and'' at the end of subparagraph (V); 
        and
            (3) by adding at the end of the following new subparagraph:
            ``(W) in the case of a disease where an intramuscular 
        biological therapy has approval of the Federal Food and Drug 
        Administration for patient self-administration upon physician 
        determination of appropriateness and is covered under 
        subparagraph (A) or (B) of this paragraph, any other 
        intramuscular and subcutaneous drug and biological with a 
        similar approved use by such Administration (including the 
        biological delivered by intramuscular injection which is 
        covered by either such subparagraph) without regard to whether 
        there is medical or other supervision with respect to the 
        administration of such drug or biological;''.
    (b) Effective Date.--The amendments made by subsection (a) shall 
apply to drugs furnished on or after January 1, 2003.
                                 <all>